← Leaderboards
Jonathan Scott Wiest
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
- Yves Pommier$0
- James L. Gulley$1,096,273
- Shyam Sharan$0
- Susan Bates$0
- John Janik$0
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorInterestPositioning AttributeLung NeoplasmsCell LineLaboratoriesSignal TransductionGenesAccountingCessation Of LifeEnvironmental Risk FactorMortality Vital StatisticsMalignant Neoplasm Of LungLeadCancer EtiologyMutationDisease ManagementDisorder RiskEarly DiagnosisCause Of DeathCancer Cell LineColon CarcinomaCancer Patient
Grant awards (30)
CCR Office of Training and Education$962,599
ZIJ · FY2019 · CA · contact PI
CCR Office of Training and Education$845,633
ZIJ · FY2018 · CA · contact PI
CCR Office of Training and Education$1,881,720
ZIJ · FY2017 · CA · contact PI
CCR Office of Training and Education$3,508,835
ZIJ · FY2016 · CA · contact PI
CCR Office of Training and Education$2,995,011
ZIJ · FY2015 · CA · contact PI
CCR Office of Training and Education$3,474,144
ZIJ · FY2014 · CA · contact PI
Genetic Alterations in Lung Cancer$164,043
ZIA · FY2014 · CA · contact PI
MAP Kinase signal transduction disruption in cancer$164,043
ZIA · FY2014 · CA · contact PI
CCR Office of Training and Education$3,252,336
ZIJ · FY2013 · CA · contact PI
Genetic Alterations in Lung Cancer$217,494
ZIA · FY2013 · CA · contact PI
MAP Kinase signal transduction disruption in cancer$217,494
ZIA · FY2013 · CA · contact PI
CCR Office of Training and Education$3,540,997
ZIJ · FY2012 · CA · contact PI
MAP Kinase signal transduction disruption in cancer$250,510
ZIA · FY2012 · CA · contact PI
Genetic Alterations in Lung Cancer$250,510
ZIA · FY2012 · CA · contact PI
CCR Office of Training and Education$3,372,509
ZIJ · FY2011 · CA · contact PI
MAP Kinase signal transduction disruption in cancer$279,834
ZIA · FY2011 · CA · contact PI
Genetic Alterations in Lung Cancer$279,834
ZIA · FY2011 · CA · contact PI
CCR Office of Training and Education$3,351,383
ZIJ · FY2010 · CA · contact PI
Genetic Alterations in Lung Cancer$242,236
ZIA · FY2010 · CA · contact PI
MAP Kinase signal transduction disruption in cancer$242,236
ZIA · FY2010 · CA · contact PI
CCR Office of Training and Education$2,268,673
ZIJ · FY2009 · CA · contact PI
MAP Kinase signal transduction disruption in cancer$244,256
ZIA · FY2009 · CA · contact PI
Genetic Alterations in Lung Cancer$244,256
ZIA · FY2009 · CA · contact PI
Genetic Alterations in Lung Cancer$215,745
Z01 · FY2008 · CA · contact PI
MAP Kinase signal transduction disruption in cancer$215,745
Z01 · FY2008 · CA · contact PI
Genetic Alterations in Lung Cancer$557,752
Z01 · FY2007 · CA · contact PI
Genetic Alterations in Lung Cancer$0
Z01 · FY2006 · BC · contact PI
Genetic Alterations in Lung Cancer$0
Z01 · FY2005 · BC
Genetic Alterations in Lung Cancer$0
Z01 · FY2004 · BC
Genetic Alterations in Lung Cancer$0
Z01 · FY2002 · BC